Skip to main content
. 2014 Nov;58(11):6462–6470. doi: 10.1128/AAC.03423-14

FIG 5.

FIG 5

Probability of pharmacokinetic/pharmacodynamic target attainment for tedizolid administered at the 200-mg dose against S. aureus at the fAUC(0–24)/MIC target ratio of 3 and the probabilities of the occurrence of specific MICs among the virtual patients simulated in this target attainment analysis.